About Thinkmolecular Technologies Private Limited
Data last updated:
Thinkmolecular Technologies Private Limited is a private limited company based in Bengaluru, Karnataka, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 01 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2020PTC136742. Its GSTIN is 29AAHCT9920C1Z5 (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ramesh Kumar Sistla (Managing Director) and Ravi Shankar Sistla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mohana #03 1st Cross Reliaable Tranquil Layout Haralur, Bengaluru, Karnataka, India – 560102.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.13 Cr, a growth of 104% compared to the previous year. For the same year it recorded a net profit of ₹92.63 Lakh (net margin 43.5%) and EBITDA of ₹1.26 Cr (EBITDA margin 59.3%). Revenue has grown at a compounded annual rate (CAGR) of 205% over three years.
The company is associated with 1 brand: thinkMolecular.
For more details, the company can be reached via its website thinkmolecular.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressMohana #03 1st Cross Reliaable Tranquil Layout Haralur, Bengaluru, Karnataka, India – 560102
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Thinkmolecular Technologies Private Limited
The main business activity of Thinkmolecular Technologies is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Thinkmolecular Technologies Private Limited FY 2025 filings available
Thinkmolecular Technologies Private Limited reported revenue of ₹2.13 Cr (up 104% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Thinkmolecular Technologies Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 205% over three years, including 104% growth in the latest year. EBITDA rose 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Thinkmolecular Technologies Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.26 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹92.63 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Thinkmolecular Technologies Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 59.3% | •••• | •••• | •••• |
| Net Profit Margin | 43.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Thinkmolecular Technologies are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anjna Hospital & Clinisearch Private Limited | ₹2.19 Cr (FY 2024) | •••• | •••• | 3063.0% | •••• | Vadodara, Gujarat, India |
| Belicia Lifesciences Private Limited | ₹2.17 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Lucknow, Uttar Pradesh, India |
| Media Options Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | 205.0% | •••• | Delhi, India |
| Metabix Private Limited | ₹2.15 Cr (FY 2024) | •••• | •••• | 108.0% | •••• | Hyderabad, Telangana, India |
| Eyestem Research Private Limited | ₹2.13 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Bangalore, Karnataka, India |
| Thinkmolecular Technologies Private Limited this company | ₹2.13 Cr (FY 2024) | •••• | •••• | 104.0% | •••• | Bengaluru, Karnataka, India |
| Sylphid Analytics Private Limited | ₹2.13 Cr (FY 2022) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Indu Data Fabricx Private Limited | ₹2.11 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Chennai, Tamil Nadu, India |
| Roorkee Research & Analytical Labs Private Limited | ₹2.1 Cr (FY 2024) | •••• | •••• | 44.0% | •••• | Hyderabad, Telangana, India |
| Redox Scientific Private Limited | ₹2.1 Cr (FY 2024) | •••• | •••• | •••• | Sanand, Gujarat, India | |
| Omicron Pharma Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Surat, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Thinkmolecular Technologies by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies Private Limited is audited by Susil and Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Susil and Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Shankar Sistla Also directs: RSSS & Associates LLP | Director | 01 Aug 2020 | 6 Years 2 Months | Current |
| Ramesh Kumar Sistla | Managing Director | 01 Aug 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Thinkmolecular Technologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies operates one associated brand: thinkMolecular. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers AI-augmented simulations for target identification and lead optimization in drug discovery. | thinkmolecular.in |
Employees and EPFO Compliance at Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ramesh Kumar Sistla was appointed as Managing Director on 01 Aug 2020.
Credit Ratings, Litigation & Regulatory Alerts for Thinkmolecular Technologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Thinkmolecular Technologies Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Thinkmolecular Technologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCT9920C1Z5 | Karnataka | Active | 31 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Thinkmolecular Technologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thinkmolecular Technologies Private Limited
Thinkmolecular Technologies is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 01 August 2020 (6+ years old) and is registered under CIN U73100KA2020PTC136742.
Thinkmolecular Technologies reported revenue of ₹2.13 Cr for FY 2024 (up 104% YoY).
Thinkmolecular Technologies has 2 current directors:
- Ramesh Kumar Sistla - Managing Director
- Ravi Shankar Sistla - Director
Thinkmolecular Technologies reported a net profit of ₹92.63 Lakh (net margin 43.5%) and EBITDA of ₹1.26 Cr (EBITDA margin 59.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Thinkmolecular Technologies is 205% over three years. In the latest year (FY 2024) revenue rose 104%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Thinkmolecular Technologies is 29AAHCT9920C1Z5, registered in Karnataka.
The CIN (Corporate Identification Number) of Thinkmolecular Technologies is U73100KA2020PTC136742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Thinkmolecular Technologies was incorporated on 01 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Thinkmolecular Technologies by revenue are Anjna Hospital & Clinisearch Private Limited, Belicia Lifesciences Private Limited, Media Options Private Limited, Metabix Private Limited, Eyestem Research Private Limited and 5 more, all in the Pharma industry (Contract Research).
Ramesh Kumar Sistla was appointed as Managing Director on 01 Aug 2020. Ravi Shankar Sistla was appointed as Director on 01 Aug 2020.
Yes, Thinkmolecular Technologies is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).